| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239617 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 6 Pages |
Abstract
The results of our study have shown that cetuximab can be combined safely with capecitabine and oxaliplatin plus RT. The low pathologic complete response rate achieved should stimulate additional preclinical investigations to establish the best sequence of triple combinations.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Claus M.D., Dirk M.D., Matthias M.D., Torsten M.D., Kathrin M.D., Igors M.D., Robert Michael M.D., Florian M.D., Axel M.D., Werner M.D., Rolf M.D.,